Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of $194.91 billion as of October 22, 2026. It is the 99th most valuable company in the world and the 63rd biggest in the United States. Its market cap has increased by 26.60% in one year.

Market Cap

194.91B

Enterprise Value

216.27B

1-Year Change

26.60%

Global Rank

#99

Country Rank

#63 United States

ChartMarket Cap Chart

Chart

Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $194.91B, an increase of 19,929.65%. That is a compound annual growth rate of 20.91%.

Market Cap History

Date	Market Cap	% Change
Oct 22, 2026	194.91B	27.99%
Dec 31, 2025	152.28B	32.28%
Dec 31, 2024	115.12B	14.04%
Dec 29, 2023	100.94B	-6.25%
Dec 30, 2022	107.68B	18.22%
Dec 31, 2021	91.08B	24.72%
Dec 31, 2020	73.03B	-11.17%
Dec 31, 2019	82.21B	1.60%
Dec 31, 2018	80.92B	-13.53%
Dec 29, 2017	93.58B	-0.81%
Dec 30, 2016	94.34B	-35.31%
Dec 31, 2015	145.83B	2.55%
Dec 31, 2014	142.21B	23.49%
Dec 31, 2013	115.15B	106.93%
Dec 31, 2012	55.65B	81.01%
Dec 30, 2011	30.74B	4.49%
Dec 31, 2010	29.42B	-24.44%
Dec 31, 2009	38.94B	-16.37%
Dec 31, 2008	46.56B	8.73%
Dec 31, 2007	42.82B	43.43%
Dec 29, 2006	29.86B	24.03%
Dec 30, 2005	24.07B	58.92%
Dec 31, 2004	15.15B	28.36%
Dec 31, 2003	11.80B	76.49%
Dec 31, 2002	6.69B	6.07%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Johnson & Johnson	627.56B
AbbVie	509.90B
Merck & Co.	365.83B
Novartis AG	290.89B
AstraZeneca	263.21B
Amgen	235.88B
Novo Nordisk	174.17B
Pfizer	171.10B

Market Cap Rankings